Men who say they have stressful jobs and also feel they exert high efforts for low reward had double the risk of heart disease compared to men free of those stressors, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed American Heart Association journal.
First Oral JAK Inhibitor Approved for Severe Alopecia Areata in Teens
The FDA approved the Janus kinase (JAK) inhibitor ritlecitinib (Litfulo) for adults and adolescents with severe alopecia areata. Ritlecitinib is the second oral JAK inhibitor
June 27, 2023